Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States
Public ClinicalTrials.gov record NCT01873417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Study identification
- NCT ID
- NCT01873417
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 237 participants
Conditions and interventions
Conditions
Interventions
- BG00012 (DMF) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013
- Primary completion
- Oct 31, 2013
- Completion
- Oct 31, 2013
- Last update posted
- Mar 20, 2017
2013
United States locations
- U.S. sites
- 37
- U.S. states
- 21
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Cullman | Alabama | 35058 | — |
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | Pasadena | California | 91105 | — |
| Research Site | Englewood | Colorado | 80113 | — |
| Research Site | Fort Collins | Colorado | 80528 | — |
| Research Site | Danbury | Connecticut | 06810 | — |
| Research Site | Maitland | Florida | 32751 | — |
| Research Site | Naples | Florida | 34102 | — |
| Research Site | North Palm Beach | Florida | 33408 | — |
| Research Site | Port Charlotte | Florida | 33952 | — |
| Research Site | Sarasota | Florida | 34239 | — |
| Research Site | St. Petersburg | Florida | 33713 | — |
| Research Site | Tampa | Florida | 33609 | — |
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Atlanta | Georgia | 30327 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | Milford | Massachusetts | 01757 | — |
| Research Site | Golden Valley | Minnesota | 55422 | — |
| Research Site | Patchogue | New York | 11772 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Greensboro | North Carolina | 27405 | — |
| Research Site | High Point | North Carolina | 27262 | — |
| Research Site | Fargo | North Dakota | 58103 | — |
| Research Site | Portland | Oregon | 97225 | — |
| Research Site | Monroeville | Pennsylvania | 15215 | — |
| Research Site | Cordova | Tennessee | 38018 | — |
| Research Site | Franklin | Tennessee | 37064 | — |
| Research Site | Knoxville | Tennessee | 37934 | — |
| Research Site | Round Rock | Texas | 78681 | — |
| Research Site | Salt Lake City | Utah | 84103 | — |
| Research Site | Richmond | Virginia | 23298 | — |
| Research Site | Roanoke | Virginia | 24018 | — |
| Research Site | Tacoma | Washington | 98405 | — |
| Research Site | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01873417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01873417 live on ClinicalTrials.gov.